신경통 치료 시장 : 치료법, 적응증, 유통 채널별 - 세계 예측(2025-2030년)

The Neuralgia Treatment Market was valued at USD 1.06 billion in 2023, expected to reach USD 1.20 billion in 2024, and is projected to grow at a CAGR of 12.41%, to USD 2.42 billion by 2030.

Neuralgia treatment refers to the management and alleviation of nerve pain, which may arise due to damaged, irritated, or dysfunctional nerves often seen in conditions like trigeminal neuralgia and postherpetic neuralgia. The necessity of neuralgia treatment stems from the significant discomfort and reduced quality of life for affected individuals, fueling an ongoing demand for effective solutions. The application of these treatments spans pharmaceuticals, such as anticonvulsants and antidepressants, to advanced therapies like nerve blocks, neuromodulation, and even surgical interventions. End-users comprise hospitals, pain management centers, and specialty clinics dedicated to neurology and neurosurgery. Market growth is being driven by increasing incidences of neuropathic pain conditions, growing patient awareness, and advancements in drug development and medical technologies. However, challenges like high treatment costs, side effects associated with long-term medication use, and a lack of definitive cures can impede market expansion. Furthermore, limited healthcare access in low-income regions can restrict treatment uptake. Opportunities lie in innovative areas like developing non-invasive neuromodulation devices, novel drug delivery systems, and personalized medicine approaches tailored to an individual's genetic makeup. Companies can also explore artificial intelligence and machine learning to enhance diagnosis and treatment strategies. Encouraging public-private partnerships and investing in research to minimize costs while maximizing efficacy can also yield substantial benefits. Despite these opportunities, regulatory hurdles, and the time-consuming nature of clinical trials remain considerable barriers. The neuralgia treatment market is characterized by rapid technological advancements and a competitive landscape where major players vie for market share, prompting constant innovation. Continually monitoring emerging trends, such as patient preferences for minimally invasive treatments and holistic approaches to pain management, will be crucial for businesses aiming to capitalize on this dynamic market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neuralgia Treatment Market

The Neuralgia Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidences of neuralgia due to the rise in the aging population
  • Government initiatives to spread awareness regarding neuralgia treatment products
• Market Restraints
  • High-cost associated with the treatment of neuralgia
• Market Opportunities
  • Technological advancement eliminates the need for drugs and surgery
  • Developing surgical and pharmacological treatment in developing economies
• Market Challenges
  • Persistent side effects from medications

Porter's Five Forces: A Strategic Tool for Navigating the Neuralgia Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neuralgia Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neuralgia Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neuralgia Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neuralgia Treatment Market

A detailed market share analysis in the Neuralgia Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neuralgia Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neuralgia Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neuralgia Treatment Market

A strategic analysis of the Neuralgia Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neuralgia Treatment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Biogen Inc., Cadila Healthcare, GLENMARK PHARMS LTD., H. Lundbeck A/S, Janssen Pharmaceuticals, Inc., Lupin Limited, Merz Pharma GmbH & Co. KGaA, Novartis AG, Pfizer Inc., Takeda Pharmaceutical Company Limited, Teikoku Pharma USA, Inc., Teva Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., and UCB Group.

Market Segmentation & Coverage

This research report categorizes the Neuralgia Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Treatment, market is studied across Drug-Based and Surgery. The Drug-Based is further studied across Anticonvulsant Medicines and Tricyclic Antidepressants. The Surgery is further studied across Balloon Compression, Glycerol Injection, Microvascular Decompression, Radiofrequency Thermal Lesioning, and Stereotactic Radiosurgery.
• Based on Indication, market is studied across Diabetic Neuropathy, Intercostal Neuralgia, Occipital Neuralgia, Peripheral Neuralgia, Postherpetic Neuralgia, and Trigeminal Neuralgia.
• Based on Distribution Channel, market is studied across Drug Stores, Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidences of neuralgia due to the rise in the aging population
    • 5.1.1.2. Government initiatives to spread awareness regarding neuralgia treatment products
  • 5.1.2. Restraints
    • 5.1.2.1. High-cost associated with the treatment of neuralgia
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancement eliminates the need for drugs and surgery
    • 5.1.3.2. Developing surgical and pharmacological treatment in developing economies
  • 5.1.4. Challenges
    • 5.1.4.1. Persistent side effects from medications
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Neuralgia Treatment Market, by Treatment

• 6.1. Introduction
• 6.2. Drug-Based
  • 6.2.1. Anticonvulsant Medicines
  • 6.2.2. Tricyclic Antidepressants
• 6.3. Surgery
  • 6.3.1. Balloon Compression
  • 6.3.2. Glycerol Injection
  • 6.3.3. Microvascular Decompression
  • 6.3.4. Radiofrequency Thermal Lesioning
  • 6.3.5. Stereotactic Radiosurgery

7. Neuralgia Treatment Market, by Indication

• 7.1. Introduction
• 7.2. Diabetic Neuropathy
• 7.3. Intercostal Neuralgia
• 7.4. Occipital Neuralgia
• 7.5. Peripheral Neuralgia
• 7.6. Postherpetic Neuralgia
• 7.7. Trigeminal Neuralgia

8. Neuralgia Treatment Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Drug Stores
• 8.3. Hospital Pharmacies
• 8.4. Online Pharmacies
• 8.5. Retail Pharmacies

9. Americas Neuralgia Treatment Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Neuralgia Treatment Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Neuralgia Treatment Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Biogen Inc.
• 3. Cadila Healthcare
• 4. GLENMARK PHARMS LTD.
• 5. H. Lundbeck A/S
• 6. Janssen Pharmaceuticals, Inc.
• 7. Lupin Limited
• 8. Merz Pharma GmbH & Co. KGaA
• 9. Novartis AG
• 10. Pfizer Inc.
• 11. Takeda Pharmaceutical Company Limited
• 12. Teikoku Pharma USA, Inc.
• 13. Teva Pharmaceuticals Ltd.
• 14. Torrent Pharmaceuticals Ltd.
• 15. UCB Group